ICMR gives its nod to plasma therapy for COVID-19 treatment
Technically called “convalescent-plasma therapy”, the treatment aims at using the immune power gained by a recovered person to treat a sick person. ICMR has given approval to the SCTIMST for carrying out the novel treatment.
The therapy, like blood transfusion, harvests the antibody from a recovered patient and ingest into a sick person. Helped by the antibody, the immune system mounts robust combat on the virus.